ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,974.07
0.00%
Dow Jones
43,297.03
0.00%
US Dollar vs MXN
20.163
-0.01%
Brent Oil
73.695
0.56%
Bitcoin
95,480.44
-3.85%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PolyPid Ltd (PYPD)

  7. PolyPid Ltd (PYPD) Noticias

PYPD

PolyPid (PYPD)

PolyPid Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PYPD
FechaHoraFuenteTítuloSímboloCompañía
12/12/202406:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PYPDPolyPid Ltd
11/12/202406:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
08/11/202415:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PYPDPolyPid Ltd
09/09/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PYPDPolyPid Ltd
30/08/202415:01Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PYPDPolyPid Ltd
12/08/202415:27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PYPDPolyPid Ltd
06/03/202415:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYPDPolyPid Ltd
06/03/202415:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PYPDPolyPid Ltd
01/03/202411:19Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYPDPolyPid Ltd
18/10/202316:07AllPennyStocks.comNew Collaboration Could Revolutionize Treatment of Chronic Spinal Cord InjuriesNASDAQ:PYPDPolyPid Ltd
22/06/202306:12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
22/05/202308:54Dow Jones NewsFDA Approves PolyPid's Trial Design for D-PLEXNASDAQ:PYPDPolyPid Ltd
17/05/202310:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PYPDPolyPid Ltd
31/03/202314:55Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PYPDPolyPid Ltd
31/03/202305:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PYPDPolyPid Ltd
24/01/202309:24Dow Jones NewsPolyPid Shares Rise 28% After Positive FDA News for D-PLEXNASDAQ:PYPDPolyPid Ltd
12/12/202208:50TipRanksAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
09/11/202213:45TipRanksPolyPid (PYPD) Gets a Buy from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
28/09/202212:35TipRanksJMP Securities Sticks to Its Buy Rating for PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
02/09/202211:15TipRanksJMP Securities Remains a Buy on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/08/202210:06TipRanksAnalysts’ Top Healthcare Picks: PolyPid (PYPD), Nuvalent (NUVL)NASDAQ:PYPDPolyPid Ltd
10/08/202210:15TipRanksJMP Securities Keeps Their Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/06/202208:29TipRanksBMO Capital Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/06/202213:25TipRanksJMP Securities Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/05/202210:25TipRanksAnalysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Nektar Therapeutics (NKTR)NASDAQ:PYPDPolyPid Ltd
12/05/202207:51TipRanksBMO Capital Keeps a Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/05/202211:49TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agenus (AGEN), Intercept Pharma (ICPT) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/02/202212:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PYPDPolyPid Ltd
04/01/202200:53TipRanksPolypid Names New CEO; Shares Jump 6.3%NASDAQ:PYPDPolyPid Ltd
15/12/202123:25TipRanksPolyPid (PYPD) Gets a Buy Rating from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
 Showing the most relevant articles for your search:NASDAQ:PYPD

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
CCOM
US500
US 500
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
CCOM
US30
US 30
NYSE
MCD
McDonalds
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados